GB2551971B - Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof - Google Patents

Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof Download PDF

Info

Publication number
GB2551971B
GB2551971B GB1611276.5A GB201611276A GB2551971B GB 2551971 B GB2551971 B GB 2551971B GB 201611276 A GB201611276 A GB 201611276A GB 2551971 B GB2551971 B GB 2551971B
Authority
GB
United Kingdom
Prior art keywords
mebeverine
pharmaceutically acceptable
pharmaceutical composition
acceptable salts
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1611276.5A
Other versions
GB2551971A (en
GB201611276D0 (en
Inventor
Patel Kamlesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syri Ltd
Original Assignee
Syri Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syri Ltd filed Critical Syri Ltd
Priority to GB1611276.5A priority Critical patent/GB2551971B/en
Publication of GB201611276D0 publication Critical patent/GB201611276D0/en
Priority to PCT/IB2017/052768 priority patent/WO2018002738A1/en
Publication of GB2551971A publication Critical patent/GB2551971A/en
Application granted granted Critical
Publication of GB2551971B publication Critical patent/GB2551971B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
GB1611276.5A 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof Active GB2551971B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1611276.5A GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof
PCT/IB2017/052768 WO2018002738A1 (en) 2016-06-29 2017-05-11 Taste masked liquid pharmaceutical composition of (rs)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]amino)butyl 3,4-dimethoxybenzoate or pharmaceutically acceptable salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1611276.5A GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof

Publications (3)

Publication Number Publication Date
GB201611276D0 GB201611276D0 (en) 2016-08-10
GB2551971A GB2551971A (en) 2018-01-10
GB2551971B true GB2551971B (en) 2020-09-16

Family

ID=56891716

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1611276.5A Active GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof

Country Status (2)

Country Link
GB (1) GB2551971B (en)
WO (1) WO2018002738A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453234A (en) * 1973-04-05 1976-10-20 Dooner Lab Liquid vehicle for pharmaceutical compositions
US5602182A (en) * 1995-01-30 1997-02-11 American Home Products Corporation Taste masking pseudoephedrine HCL containing liquids
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
WO2002072102A1 (en) * 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
WO2003011306A1 (en) * 2001-07-31 2003-02-13 Wyeth Sucralose formulations to mask unpleasant tastes
WO2008011126A2 (en) * 2006-07-21 2008-01-24 Lyne Laboratories Liquid compositions of calcium acetate
EP2926810A1 (en) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453234A (en) * 1973-04-05 1976-10-20 Dooner Lab Liquid vehicle for pharmaceutical compositions
US5602182A (en) * 1995-01-30 1997-02-11 American Home Products Corporation Taste masking pseudoephedrine HCL containing liquids
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
WO2002072102A1 (en) * 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
WO2003011306A1 (en) * 2001-07-31 2003-02-13 Wyeth Sucralose formulations to mask unpleasant tastes
WO2008011126A2 (en) * 2006-07-21 2008-01-24 Lyne Laboratories Liquid compositions of calcium acetate
EP2926810A1 (en) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Mebeverine 50 mg/5ml Sugar Free Oral Suspension, available from: https://imedi.co.uk/mebeverine-50mg-5ml-sugar-free-oral-suspension, Online 06/2015 [Accessed 23 November 2019] *

Also Published As

Publication number Publication date
GB2551971A (en) 2018-01-10
GB201611276D0 (en) 2016-08-10
WO2018002738A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
HK1244704A1 (en) Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
ZA201808476B (en) Stable liquid pharmaceutical preparation
ZA201901590B (en) Liquid pharmaceutical composition
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
PL3515420T3 (en) Pharmaceutical compositions for use in the therapy of blepharitis
ZA201901736B (en) Liquid pharmaceutical composition
IL248090A0 (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
IL246630B (en) Pyrimidine pyrazolyl derivatives and pharmaceutical compositions containing them
IL260040A (en) Complexes of celecoxib and its salts and derivatives process for the preparation thereof and pharmaceutical compositions containing them
GB201819957D0 (en) Novel quinazolinone derivatives inhibiting piek and pharmaceutical composition containing same
IL250306B (en) Heterocyclyl-carbonyl derivatives of indazole and pyrazolopyridine and pharmaceutical compositions comprising them
HK1255313A1 (en) Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof
ZA201807125B (en) Pharmaceutical composition of dapagliflozin
GB2548424B (en) Liquid pharmaceutical composition of clonidine
SG10202008700VA (en) α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
GB201718468D0 (en) Stable liquid pharmaceutical compositions of bortezomb
PT3503885T (en) Pharmaceutical composition and methods of uses
GB2564444B (en) Liquid pharmaceutical composition of flecainide
IL251559A0 (en) Pharmaceutical composition of fused aminodihydrothiazine derivative
IL267279A (en) Pharmaceutical formulations of suvorexant
HK1243351A1 (en) Pharmaceutical composition comprising pyridopyrimidine derivative or pharmaceutically acceptable salt thereof
GB2551971B (en) Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof
IL257689A (en) Pharmaceutical compositions and methods for the treatment of hypoxia-related diseases
PL3328385T3 (en) Dosage form of vinca alkaloid drug
EP3222271A4 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20230629

S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Free format text: APPLICATION FILED